Acadia Pharmaceuticals | ACAD - EPS Earnings Per Share



Acadia Pharmaceuticals reported $0.16 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.14 0.20 Nov/11 2025
FY2025Q2 Jun/2025 0.16 0.15 0.20 Aug/06 2025
FY2025Q1 Mar/2025 0.11 0.01 0.10 May/07 2025
FY2024Q4 Dec/2024 0.86 0.22 0.28 Feb/26 2025
FY2024Q3 Sep/2024 0.20 0.14 -0.40 Nov/06 2024
FY2024Q2 Jun/2024 0.20 0.18 0.01 Aug/06 2024
FY2024Q1 Mar/2024 0.10 0.05 -0.27 May/08 2024
FY2023Q4 Dec/2023 0.28 0.29 -0.26 Feb/27 2024
FY2023Q3 Sep/2023 -0.40 -0.45 -0.17 Nov/02 2023
FY2023Q2 Jun/2023 0.01 -0.03 -0.21 Aug/02 2023
FY2023Q1 Mar/2023 -0.27 -0.21 -0.33 May/08 2023
FY2022Q4 Dec/2022 -0.26 -0.24 -0.27 Feb/27 2023


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
ALKERMES USD 0.52 0.39 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Corcept Therapeutics USD 0.29 0.12 Jun/2025
Cytokinetics USD -1.12 0.24 Jun/2025
Eisai JPY 51.35 47.73 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
J&J USD 2.77 0 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Prothena USD -2.34 1.26 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025